» Articles » PMID: 34406119

Multi-syndrome, Multi-gene Risk Modeling for Individuals with a Family History of Cancer with the Novel R Package PanelPRO

Overview
Journal Elife
Specialty Biology
Date 2021 Aug 18
PMID 34406119
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Identifying individuals who are at high risk of cancer due to inherited germline mutations is critical for effective implementation of personalized prevention strategies. Most existing models focus on a few specific syndromes; however, recent evidence from multi-gene panel testing shows that many syndromes are overlapping, motivating the development of models that incorporate family history on several cancers and predict mutations for a comprehensive panel of genes. We present PanelPRO, a new, open-source R package providing a fast, flexible back-end for multi-gene, multi-cancer risk modeling with pedigree data. It includes a customizable database with default parameter values estimated from published studies and allows users to select any combinations of genes and cancers for their models, including well-established single syndrome BayesMendel models (BRCAPRO and MMRPRO). This leads to more accurate risk predictions and ultimately has a high impact on prevention strategies for cancer and clinical decision making. The package is available for download for research purposes at https://projects.iq.harvard.edu/bayesmendel/panelpro.

Citing Articles

Impact of population screening for Lynch syndrome insights from the All of Us data.

Park J, Karnati H, Rustgi S, Hur C, Kong X, Kastrinos F Nat Commun. 2025; 16(1):523.

PMID: 39788943 PMC: 11718231. DOI: 10.1038/s41467-024-52562-5.


Bayesian meta-analysis of penetrance for cancer risk.

Ruberu T, Braun D, Parmigiani G, Biswas S Biometrics. 2024; 80(2).

PMID: 38819308 PMC: 11140851. DOI: 10.1093/biomtc/ujae038.


Meta-Analysis of Breast Cancer Risk for Individuals with PALB2 Pathogenic Variants.

Ruberu T, Braun D, Parmigiani G, Biswas S medRxiv. 2023; .

PMID: 37398422 PMC: 10312825. DOI: 10.1101/2023.05.31.23290791.


Combining Breast Cancer Risk Prediction Models.

Guan Z, Huang T, McCarthy A, Hughes K, Semine A, Uno H Cancers (Basel). 2023; 15(4).

PMID: 36831433 PMC: 9953824. DOI: 10.3390/cancers15041090.


MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome.

Knapp S, Revette A, Underhill-Blazey M, Stopfer J, Ukaegbu C, Poulin C Cancers (Basel). 2023; 15(2).

PMID: 36672340 PMC: 9856567. DOI: 10.3390/cancers15020391.


References
1.
Bishop D, Demenais F, Goldstein A, Bergman W, Bishop J, Bressac-de Paillerets B . Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002; 94(12):894-903. DOI: 10.1093/jnci/94.12.894. View

2.
Tyrer J, Duffy S, Cuzick J . A breast cancer prediction model incorporating familial and personal risk factors. Stat Med. 2004; 23(7):1111-30. DOI: 10.1002/sim.1668. View

3.
Elston R, Stewart J . A general model for the genetic analysis of pedigree data. Hum Hered. 1971; 21(6):523-42. DOI: 10.1159/000152448. View

4.
Madsen T, Braun D, Peng G, Parmigiani G, Trippa L . Efficient computation of the joint probability of multiple inherited risk alleles from pedigree data. Genet Epidemiol. 2018; 42(6):528-538. PMC: 6129424. DOI: 10.1002/gepi.22130. View

5.
Welch B, Wiley K, Pflieger L, Achiangia R, Baker K, Hughes-Halbert C . Review and Comparison of Electronic Patient-Facing Family Health History Tools. J Genet Couns. 2018; 27(2):381-391. PMC: 5861014. DOI: 10.1007/s10897-018-0235-7. View